It is crucial to consider objective indicators of inflammatory activity, such as MRI findings or elevated C-reactive protein (CRP) levels, when initiating biological treatments for patients with axSpA lacking radiographic sacroiliitis. This evidence concerns the gene CRP and Sacroiliac arthritis.